RNA Sequencing of Individual Versus Wastewater - SARS-CoV2 : A Comparison Between Individual and Wastewater SARS-CoV2 RNA Sequencing
The aim is to compare the percentage of the different SARS-CoV2 lineages that are detected in wastewater samples with matched clinical samples. About 1,400 swab samples from patients living in Nice were tested by Biogroup between Oct 19th and Oct 23rd (Week 43 of 2020). The sequence of 81 PCR positive samples, corresponding to all samples that were unambiguously assigned to one of the wastewater catchment areas and their lineage was determined. These values were compared to values measured in wastewater..
Medienart: |
Klinische Studie |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
ClinicalTrials.gov - (2021) vom: 13. Sept. Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
610 |
---|
Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: September 13, 2021, Last downloaded: ClinicalTrials.gov processed this data on September 13, 2021, Last updated: September 15, 2021 |
---|
Study ID: |
NCT05041764 |
---|---|
Veröffentlichungen zur Studie: |
|
fisyears: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
CTG007901224 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | CTG007901224 | ||
003 | DE-627 | ||
005 | 20230425200102.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210915s2021 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)CTG007901224 | ||
035 | |a (UBBS_Klinische_Studien)NCT05041764 | ||
035 | |a (UBBS_Klinische_Studien)21DSP-IPMC01 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a RNA Sequencing of Individual Versus Wastewater - SARS-CoV2 |b A Comparison Between Individual and Wastewater SARS-CoV2 RNA Sequencing |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: September 13, 2021, Last downloaded: ClinicalTrials.gov processed this data on September 13, 2021, Last updated: September 15, 2021 | ||
520 | |a The aim is to compare the percentage of the different SARS-CoV2 lineages that are detected in wastewater samples with matched clinical samples. About 1,400 swab samples from patients living in Nice were tested by Biogroup between Oct 19th and Oct 23rd (Week 43 of 2020). The sequence of 81 PCR positive samples, corresponding to all samples that were unambiguously assigned to one of the wastewater catchment areas and their lineage was determined. These values were compared to values measured in wastewater. | ||
650 | 2 | |a Virus Diseases | |
650 | 4 | |a Medical Condition: Infection Viral | |
650 | 4 | |a Study Type: Observational | |
650 | 4 | |a Recruitment Status: Completed | |
650 | 4 | |a 610 | |
773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2021) vom: 13. Sept. |
773 | 1 | 8 | |g year:2021 |g day:13 |g month:09 |
856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT05041764 |z kostenfrei |3 Volltext |
912 | |a GBV_CTG | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2021 |b 13 |c 09 |